Eggers Shoshannah, et al.
BMC infectious diseases, 2018
Abstract
Background
Infection by Staphylococcus aureus (S. aureus) is a major cause of morbidity and mortality. Colonization by S. aureus increases the risk of infection. Little is known about decolonization strategies for S. aureus beyond antibiotics, however probiotics represent a promising alternative. A randomized controlled trial was conducted to determine the efficacy of Lactobacillus rhamnosus (L. rhamnosus) HN001 in reducing carriage of S. aureus at multiple body sites.
Methods
One hundred thirteen subjects, positive for S. aureus carriage, were recruited from the William S. Middleton Memorial Medical Center, Madison, WI, USA, and randomized by initial site of colonization, either gastrointestinal (GI) or extra-GI, to 4-weeks of oral L. rhamnosus HN001 probiotic, or placebo. Nasal, oropharyngeal, and axillary/groin swabs were obtained, and serial blood and fecal samples were collected. Differences in prevalence of S. aureus carriage at the end of the 4-weeks of treatment were assessed.
Results
The probiotic and placebo groups were similar in age, gender, and health history at baseline. S. aureus colonization within the stool samples of the extra-GI group was 15% lower in the probiotic than placebo group at the endpoint of the trial. Those in the probiotic group compared to the placebo group had 73% reduced odds (OR 0.27, 95% CI 0.07-0.98) of methicillin-susceptible S. aureus presence, and 83% reduced odds (OR 0.17, 95% CI 0.04-0.73) of any S. aureus presence in the stool sample at endpoint.
Conclusion
Use of daily oral L. rhamnosus HN001 reduced odds of carriage of S. aureus in the GI tract, however it did not eradicate S. aureus from other body sites.
Trial registration
ClinicalTrials.gov Identifier: NCT01321606. Registered March 21, 2011.
Keywords
Clinical trial; Lactobacilli; MRSA; Probiotics; Veterans.
Conflict of interest statement
Ethics approval and consent to participateThis study was approved by the University of Wisconsin-Madison Institutional Review Board (#2011–0063). All participants completed written informed consent prior to enrollment into the study.
Consent for publication
Not applicable.
Competing interests
SE’s spouse is employed by DuPont Nutrition and Health, who supplied the trial treatments, however this association had no influence on the conduct or outcome of this trial. All other authors have no competing interest.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
| PMID: | 29540160 |
|---|---|
| DOI: | 10.1186/s12879-018-3028-6 |
| PMCID (Free PMC Article): | PMC5853063 |
| Category: | General properties of Lactobacillus Rhamnosus |
Articles similar to "Effect of Lactobacillus Rhamnosus HN001 on Carriage of Staphylococcus Aureus: Results of the Impact of Probiotics for Reducing Infections in Veterans (IMPROVE) Study."
- The properties of Lactobacillus Rhamnosus: Survival of Lactic Acid Bacteria in the Human Stomach and Adhesion to Intestinal Cells. (The survival of four strains of lactic acid bacteria in human gastric juice, in vivo and in vitro, and in buffered saline, pH 1 to 5, has been investigated...)
- The properties of Lactobacillus Rhamnosus: Ecological Role of Lactobacilli in the Gastrointestinal Tract: Implications for Fundamental and Biomedical Research. (Bacteria belonging to the genus Lactobacillus are members of the lactic acid bacteria (LAB), a broadly defined group characterized by the formation of lactic acid as the sole or main end product of carbohydrate metabolism...)
- The properties of Lactobacillus Rhamnosus: Probiotics, Prebiotics, and Synbiotics. (According to the German definition, probiotics are defined viable microorganisms, sufficient amounts of which reach the intestine in an active state and thus exert positive health effects...)
- The properties of Lactobacillus Rhamnosus: Adherence Capability and Safety Assessment of an Indigenous Probiotic Strain Lactobacillus Rhamnosus MTCC-5897. (With the growing interest in probiotic microorganisms based on their well established immense health benefits, the present investigation was aimed to assess the adhesion potential and safety of probiotic Lactobacillus rhamnosus MTCC- 5897 (LR) before it can be put into a probiotic formulations...)